Press the button and be introduced to a new random company!

Introduce me >

Social media

facebook   Follow us on Twitter

Coverage

Probi

Probi

Send subscription Close

Probi develops, produces, markets and sells probiotics globally to food, health and pharmaceutical companies. Probiotics are living microorganisms that have a beneficial effect on health when taken in a sufficient amount. The company's research focuses primarily on gastrointestinal health, immune systems, nutritional and iron intake and metabolic health. The Group is organized in three geographical segments – Americas, EMEA and APAC.

Sustainability information

We note several risk factors for Probi, including market risk, partnership risk, competition, legal and regulatory risk, product development risk, currency risk and macroeconomic risk. In addition, Probi is dependent on a number of key customers that constitutes a large part of the Group's total sales.

Financials

SEKm 2025 2026e 2027e
Sales 667 705 N/A
Sales growth (%) 6,2 5,8 -100
EBITDA 135 152 N/A
EBITDA margin (%) 20,3 21,6 N/A
EBIT adj. 32 48 0
EBIT adj. margin (%) 4,8 6,9 N/A
Pretax profit 37 53 0
EPS 2,91 4,2 N/A
EPS growth (%) N/A 44,2 -100
EPS adj. 7,09 8,37 N/A
DPS 1,94 2,53 N/A
EV/EBITDA (x) 26,4 23,1 N/A
EV/EBIT adj. (x) 111,7 72,5 N/A
P/E (x) N/A 82,9 N/A
P/E adj. (x) 49,1 41,6 N/A
EV/sales (x) 5,36 4,98 N/A
FCF yield (%) 2 2,4 0
Le. adj. FCF yld. (%) 1,6 2 0
Dividend yield (%) 0,6 0,7 0
Net IB debt/EBITDA (x) -2,4 -2,5 N/A
Le. adj. ND/EBITDA (x) -3,4 -3,4 N/A
SEKm 2025 2026e 2027e
Sales 667 705 N/A
COGS -423 -437 N/A
Gross profit 243 268 0
Other operating items -108 -116 0
EBITDA 135 152 N/A
Depreciation and amortisation -56 -56 0
of which leasing depreciation -16 -16 N/A
EBITA 80 96 N/A
EO Items N/A N/A N/A
Impairment and PPA amortisation -48 -48 0
EBIT 32 48 N/A
Net financial items 5 5 N/A
Pretax profit 37 53 0
Tax -4 -5 N/A
Net profit 33 48 0
Minority interest 0 0 N/A
Net profit discontinued 0 0 N/A
Net profit to shareholders 33 48 0
EPS 2,91 4,2 N/A
EPS adj. 7,09 8,37 N/A
Total extraordinary items after tax 0 0 0
Leasing payments -16 -16 N/A
Tax rate (%) 10 10 N/A
Gross margin (%) 36,5 38,1 N/A
EBITDA margin (%) 20,3 21,6 N/A
EBITA margin (%) 11,9 13,6 N/A
EBIT margin (%) 4,8 6,9 N/A
Pre-tax margin (%) 5,5 7,5 N/A
Net margin (%) 5 6,8 N/A
Growth Rates y-o-y N/A N/A N/A
Sales growth (%) 6,2 5,8 -100
EBITDA growth (%) 21 12,5 -100
EBITA growth (%) 40,7 20,7 -100
EBIT growth (%) N/A 51,5 -100
Net profit growth (%) 117,4 44,2 -100
EPS growth (%) N/A 44,2 -100
Profitability N/A N/A N/A
ROE (%) 2,4 3,4 0
ROE adj. (%) 5,9 6,8 0
ROCE (%) 2,7 3,7 0
ROCE adj. (%) 6 7 0
ROIC (%) 6,7 8,3 N/A
ROIC adj. (%) 6,7 8,3 N/A
Adj. earnings numbers N/A N/A N/A
EBITDA adj. 135 152 0
EBITDA adj. margin (%) 20,3 21,6 N/A
EBITDA lease adj. 120 136 N/A
EBITDA lease adj. margin (%) 17,9 19,3 N/A
EBITA adj. 80 96 0
EBITA adj. margin (%) 11,9 13,6 N/A
EBIT adj. 32 48 0
EBIT adj. margin (%) 4,8 6,9 N/A
Pretax profit Adj. 84 101 0
Net profit Adj. 81 95 0
Net profit to shareholders adj. 81 95 0
Net adj. margin (%) 12,1 13,5 N/A
SEKm 2025 2026e 2027e
EBITDA 135 152 N/A
Goodwill 342 342 N/A
Net financial items 5 5 N/A
Other intangible assets 277 243 0
Paid tax -4 -5 N/A
Tangible fixed assets 142 138 N/A
Non-cash items 0 0 N/A
Right-of-use asset 75 75 N/A
Cash flow before change in WC 136 151 0
Total other fixed assets 81 81 0
Change in working capital -6 -7 0
Fixed assets 918 879 0
Operating cash flow 131 145 N/A
Inventories 129 133 N/A
Capex tangible fixed assets -30 -28 N/A
Receivables 66 70 N/A
Capex intangible fixed assets -23 -21 N/A
Other current assets 21 21 N/A
Acquisitions and Disposals 0 0 0
Cash and liquid assets 408 466 N/A
Free cash flow 78 95 0
Total assets 1542 1569 0
Dividend paid -17 -22 N/A
Shareholders equity 1386 1412 0
Share issues and buybacks 0 0 0
Minority N/A N/A N/A
Leasing liability amortisation -16 -16 N/A
Total equity 1386 1412 0
Other non-cash items 0 0 -379
Long-term debt N/A N/A N/A
Pension debt N/A N/A N/A
Convertible debt N/A N/A N/A
Leasing liability 81 81 0
Total other long-term liabilities 5 5 0
Short-term debt 0 0 N/A
Accounts payable 38 39 N/A
Other current liabilities 31 31 0
Total liabilities and equity 1542 1569 0
Net IB debt -327 -384 0
Net IB debt excl. pension debt -327 -384 0
Net IB debt excl. leasing -408 -466 0
Capital employed 1467 1493 0
Capital invested 1059 1027 0
Working capital 147 154 0
EV breakdown N/A N/A N/A
Market cap. diluted (m) 3965 3965 0
Net IB debt adj. -327 -384 N/A
Market value of minority 0 0 N/A
Reversal of shares and participations -67 -67 0
Reversal of conv. debt assumed equity N/A N/A N/A
EV 3571 3514 0
Total assets turnover (%) 43,5 45,3 0
Working capital/sales (%) 21,6 21,3 N/A
Financial risk and debt service N/A N/A N/A
Net debt/equity (%) -23,6 -27,2 N/A
Net debt / market cap (%) -8,2 -9,7 N/A
Equity ratio (%) 89,9 90 N/A
Net IB debt adj. / equity (%) -23,6 -27,2 N/A
Current ratio 8,98 9,75 N/A
EBITDA/net interest 28 32,8 N/A
Net IB debt/EBITDA (x) -2,4 -2,5 N/A
Net IB debt/EBITDA lease adj. (x) -3,4 -3,4 N/A
Interest coverage 35,6 44,8 N/A
SEKm 2025 2026e 2027e
Shares outstanding adj. 11 11 N/A
Diluted shares adj. 11 11 0
EPS 2,91 4,2 N/A
Dividend per share 1,94 2,53 N/A
EPS adj. 7,09 8,37 N/A
BVPS 121,63 123,89 N/A
BVPS adj. 67,25 72,54 N/A
Net IB debt/share -28,68 -33,72 N/A
Share price 348 348 348
Market cap. (m) 3965 3965 0
Valuation N/A N/A N/A
P/E (x) N/A 82,9 N/A
EV/sales (x) 5,36 4,98 N/A
EV/EBITDA (x) 26,4 23,1 N/A
EV/EBITA (x) 44,9 36,6 N/A
EV/EBIT (x) 111,7 72,5 N/A
Dividend yield (%) 0,6 0,7 0
FCF yield (%) 2 2,4 0
Le. adj. FCF yld. (%) 1,6 2 0
P/BVPS (x) 2,86 2,81 N/A
P/BVPS adj. (x) 5,17 4,8 348
P/E adj. (x) 49,1 41,6 N/A
EV/EBITDA adj. (x) 26,4 23,1 N/A
EV/EBITA adj. (x) 44,9 36,6 N/A
EV/EBIT adj. (x) 111,7 72,5 N/A
EV/CE (x) 2,4 2,4 N/A
Investment ratios N/A N/A N/A
Capex/sales (%) 8 7 N/A
Capex/depreciation 1,3 1,2 N/A
Capex tangibles / tangible fixed assets 21,1 20,4 N/A
Capex intangibles / definite intangibles 8,4 8,7 N/A
Depreciation on intang / def. intang 3 3 N/A
Depreciation on tangibles / tangibles 22,39 23,26 N/A

Equity research

Read earlier research

Media

Probi - Company presentation with CEO Anita Johansen & CFO Per Lindblad
Probi - Company presentation with CEO Tom Rönnlund & CFO Henrik Lundkvist

View more media

Main shareholders - Probi

Main shareholders Share capital % Voting shares % Verified
Symrise AG 50.3 % 50.3 %
Swedbank Robur Fonder 11.4 % 11.4 %
Fjärde AP-fonden 8.6 % 8.6 %
Probi Aktiebolag 2.1 % 2.1 %
Avanza Pension 1.1 % 1.1 %
SEB Fonder 1.0 % 1.0 %
SEBinvest 0.8 % 0.8 %
Catella Fonder 0.8 % 0.8 %
Länsförsäkringar Fonder 0.8 % 0.8 %
XACT Fonder 0.4 % 0.4 %